IL6 and infection: This observation, coupled with the results suggesting that the IL-6 releases significantly increased in a dose-dependent manner for CPS2 supplement to a similar level as that with HA9801 infection under the co-treatment with 20 μg PTX3 (Figure 5C), verified that an excessive inflammatory response triggered by CPS2 and PTX3 caused mice deaths.